- Home
- U vs HALO Comparison
U vs HALO Comparison
Compare U & HALO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- U
- HALO
- Stock Information
- Founded
- U 2004
- HALO 1998
- Country
- U United States
- HALO United States
- Employees
- U N/A
- HALO N/A
- Industry
- U Retail: Computer Software & Peripheral Equipment
- HALO Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- U Technology
- HALO Health Care
- Exchange
- U Nasdaq
- HALO Nasdaq
- Market Cap
- U 7.7B
- HALO 7.4B
- IPO Year
- U 2020
- HALO N/A
- Fundamental
- Price
- U $21.24
- HALO $48.95
- Analyst Decision
- U Buy
- HALO Buy
- Analyst Count
- U 13
- HALO 9
- Target Price
- U $23.79
- HALO $63.56
- AVG Volume (30 Days)
- U 8.5M
- HALO 3.0M
- Earning Date
- U 05-07-2025
- HALO 05-06-2025
- Dividend Yield
- U N/A
- HALO N/A
- EPS Growth
- U N/A
- HALO 55.40
- EPS
- U N/A
- HALO 3.76
- Revenue
- U $1,787,875,000.00
- HALO $1,084,306,000.00
- Revenue This Year
- U N/A
- HALO $24.79
- Revenue Next Year
- U $9.62
- HALO $22.65
- P/E Ratio
- U N/A
- HALO $13.03
- Revenue Growth
- U N/A
- HALO 25.64
- 52 Week Low
- U $13.90
- HALO $41.28
- 52 Week High
- U $30.88
- HALO $70.51
- Technical
- Relative Strength Index (RSI)
- U 51.70
- HALO 34.26
- Support Level
- U $19.81
- HALO $47.50
- Resistance Level
- U $22.56
- HALO $69.94
- Average True Range (ATR)
- U 1.00
- HALO 3.34
- MACD
- U 0.04
- HALO -1.51
- Stochastic Oscillator
- U 49.43
- HALO 6.30
About U Unity Software Inc.
Unity Software Inc provides a software platform for creating and operating interactive, real-time 3D content. The platform can be used to create, run, and monetize interactive, real-time 2D and 3D content for mobile phones, tablets, PCs, consoles, and augmented and virtual reality devices. The business is spread across the United States, Greater China, EMEA, APAC, and other Americas, and key revenue is derived from the EMEA region. The products are used in the gaming industry, retail, automotive, architecture, engineering, and construction.
About HALO Halozyme Therapeutics Inc.
Halozyme Therapeutics Inc is a biotechnology company focused on developing and commercializing novel oncology therapies. The company seeks to create therapies focused on human enzymes that alter tumors. Halozyme focuses on developing its proprietary products in therapeutic areas with a focus on oncology, and licensing its technology to biopharmaceutical companies to collaboratively develop products. The company's operations are based in the United States, with minimal long-lived assets located internationally.